Header Logo

Connection

ARGUN AKCAKANAT to Neoplasm Metastasis

Back to Details
This is a "connection" page, showing publications ARGUN AKCAKANAT has written about Neoplasm Metastasis.
ARGUN AKCAKANAT
Connection Strength
0.033
Neoplasm Metastasis
  1. Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation. Breast Cancer Res. 2019 07 05; 21(1):78.
    View in: PubMed
    Score: 0.020
  2. Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer. Breast Cancer Res. 2012 Oct 26; 14(5):R138.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.